Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • BCA Protein Assay Kit: Reliable Protein Quantification for R

    2026-04-27

    BCA Protein Assay Kit: Reliable Protein Quantification for Research

    Executive Summary: The BCA Protein Assay Kit (SKU: K4101) from APExBIO uses the bicinchoninic acid (BCA) method to provide sensitive, reproducible quantification of proteins in biological samples (source: product_spec). The kit detects protein concentrations as low as 25 μg/mL and as little as 0.5 μg per assay, making it suitable for samples with limited volume. It operates on the well-characterized biuret reaction, producing a stable colorimetric readout at 562 nm, proportional to protein concentration (source: paper). The kit supports rigorous workflows in biochemical and molecular biology research, including the study of blood–brain barrier (BBB) disruption and endothelial pyroptosis (source: internal_link_1). All kit components remain stable for up to one year at 4°C (source: product_spec).

    Biological Rationale

    The accurate measurement of protein concentration is foundational for molecular biology, biochemical research, and translational studies. Quantitative protein assays, such as the BCA Protein Assay Kit, are essential for analyzing protein levels in cell lysates, tissues, and purified samples. This is particularly important in research focused on mechanisms like HIV-1 gp120-induced disruption of the blood–brain barrier (BBB), where precise quantification of proteins in brain microvascular endothelial cell lysates underpins reproducibility and interpretation of downstream assays (source: internal_link_2). The BCA method's compatibility with detergents and reducing agents further enhances its utility in complex sample matrices commonly encountered in neuroinflammation and BBB research (source: internal_link_3).

    Mechanism of Action of BCA Protein Assay Kit

    The BCA Protein Assay Kit operates via the bicinchoninic acid (BCA) method, a colorimetric assay based on the biuret reaction. In alkaline conditions, protein peptide bonds reduce cupric ions (Cu2+) from copper sulfate to cuprous ions (Cu+). The generated Cu+ ions form a stable purple complex with bicinchoninic acid, which absorbs strongly at 562 nm. The absorbance intensity correlates linearly with the amount of protein present in the sample, enabling accurate quantification (source: product_spec). The kit contains two reagents (A and B) and BSA protein standards, streamlined for straightforward workflow integration.

    Evidence & Benchmarks

    • Detects protein concentrations as low as 25 μg/mL, with a minimum detection limit of 0.5 μg per assay (source: product_spec).
    • Exhibits linear response between 50–2,000 μg/mL protein, enabling accurate quantification across a broad dynamic range (source: product_spec).
    • Requires only 1–20 μL of sample, conserving precious or low-yield lysates (source: product_spec).
    • Demonstrates compatibility with common lysis buffers and detergents, supporting protein detection in challenging matrices such as brain microvascular endothelial cell lysates (source: internal_link_1).
    • Used in studies of HIV-1 gp120-induced BBB disruption, where precise protein quantification in BMEC lysates is critical for interpreting pyroptosis and barrier integrity assays (source: paper).

    This article expands on prior coverage (see BCA Protein Assay Kit: Precision Protein Quantification for BBB Research) by detailing protocol parameters, evidence benchmarks, and common pitfalls for researchers applying the kit in translational neurovascular studies.

    Applications, Limits & Misconceptions

    The BCA Protein Assay Kit is widely used for:

    • Quantifying total protein in cell lysates, tissue extracts, and purified fractions.
    • Supporting workflows in western blotting, ELISA, and enzyme kinetics.
    • Enabling robust protein detection in neuroinflammation research, including models of BBB disruption and endothelial pyroptosis (source: internal_link_2).

    Common Pitfalls or Misconceptions

    • Interference by Reducing Agents: Excess DTT, TCEP, or beta-mercaptoethanol may affect the biuret reaction, leading to falsely elevated readings.
    • Sample Compatibility: High concentrations of chelators (e.g., EDTA) or detergents can interfere with copper reduction or BCA complex formation.
    • Linearity Limits: Quantification outside the 50–2,000 μg/mL range may not be reliable; samples should be diluted to fall within this range (source: product_spec).
    • Protein-to-Protein Variability: The assay is calibrated using BSA; other proteins may yield slightly different responses due to differing amino acid compositions.
    • Color Stability: The BCA–Cu+ complex is stable for approximately 30–60 minutes; prompt measurement is recommended (workflow_recommendation).

    Workflow Integration & Parameters

    Protocol Parameters

    • assay | 25–2,000 μg/mL protein | total protein quantification in biological samples | ensures accurate measurement in cell lysates and extracts | product_spec
    • assay | 1–20 μL sample volume | low-volume or precious samples | minimizes sample consumption for downstream applications | product_spec
    • storage | 4°C, stable up to 12 months | all components | preserves reagent stability and reliability | product_spec
    • readout | absorbance at 562 nm | colorimetric quantification | optimal for plate readers and spectrophotometers | product_spec
    • compatibility | common buffers, mild detergents | cell/tissue lysates | supports workflows in neuroinflammation and BBB research | internal_link_1
    • recommendation | dilute samples with high detergent/reducing agent content | problematic sample types | prevents interference with BCA reaction | workflow_recommendation

    Conclusion & Outlook

    The BCA Protein Assay Kit (K4101) from APExBIO delivers robust, reproducible protein quantification essential for molecular biology and biochemical research (source: product_spec). Its compatibility with complex lysates, including those from brain microvascular endothelial cells, supports translational studies of BBB disruption and neuroinflammation (source: paper). As research into HIV-1 gp120-induced endothelial pyroptosis advances, the kit's reliability in protein concentration measurement underpins rigorous experimental design and interpretation. For further protocol optimization and troubleshooting, researchers are encouraged to consult the official product page and recent comparative studies. This article extends prior coverage (see BCA Protein Assay Kit: Precision Protein Quantification f...) by focusing on evidence-backed benchmarks and common limits in BBB research workflows.